Published in Infect Immun on November 01, 1979
Resistance to Plasmodium chabaudi in B10 mice: influence of the H-2 complex and testosterone. Infect Immun (1988) 1.04
Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. J Exp Med (1975) 13.69
THE IMMUNOLOGICAL BASIS OF ACQUIRED CELLULAR RESISTANCE. J Exp Med (1964) 13.28
The H-2 major histocompatibility complex and the I immune response region: genetic variation, function, and organization. Adv Immunol (1975) 9.19
Cellular kinetics associated with the development of acquired cellular resistance. J Exp Med (1969) 3.94
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Structural and serological properties of murine Ia alloantigens. Transplant Rev (1976) 2.35
T-cell activation in murine malaria. Nature (1975) 2.23
Serologic and genetic aspects of murine Ia antigens. Transplant Rev (1976) 2.02
Immune complex disease in chronic viral infections. J Exp Med (1971) 1.69
Macrophage activation during experimental murine brucellosis: a basis for chronic infection. Infect Immun (1979) 1.54
Lymphocytic choriomeningitis. Pathogenesis. Prog Med Virol (1974) 1.47
Functional heterogeneity of lymphocytic choriomeningitis virus-specfic T lymphocytes. I. Identification of effector amd memory subsets. J Exp Med (1975) 1.37
Lymphocytic choriomeningitis virus-induced immunosuppression: a virus-induced macrophage defect. J Immunol (1976) 1.20
Spleen cell changes during fatal and self-limiting malarial infections of mice. Immunology (1978) 1.08
Ia antigenic specificities are oligosaccharide in nature: hapten-inhibition studies. J Exp Med (1977) 0.96
Mechanisms of hemopoietic and immunological dysfunction induced by lymphocytic choriomeningitis virus. Infect Immun (1978) 0.95
Secretion of Ia antigens by a subpopulation of T cells which are Ly-1+, Ly-2-, and Ia-. J Exp Med (1976) 0.88
Mitogens and T-independent antigens stimulate T lymphocytes to secrete La antigens. Cell Immunol (1977) 0.78
Determination of lymphocyte division by flow cytometry. J Immunol Methods (1994) 11.48
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature (1978) 6.59
Immunization against blood-stage rodent malaria using purified parasite antigens. Nature (1981) 4.40
A procedure for removing red cells and dead cells from lymphoid cell suspensions. J Immunol Methods (1975) 4.22
Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease. Nature (1972) 4.08
Activated macrophages in congenitally athymic "nude mice" and in lethally irradiate mice. J Immunol (1975) 3.96
Biosynthesis and processing of a Plasmodium falciparum schizont antigen recognized by immune serum and a monoclonal antibody. J Exp Med (1982) 3.88
Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis. Infect Immun (1978) 3.24
New fluorescent dyes for lymphocyte migration studies. Analysis by flow cytometry and fluorescence microscopy. J Immunol Methods (1990) 3.19
Cloning of mammalian heparanase, an important enzyme in tumor invasion and metastasis. Nat Med (1999) 3.06
Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03
Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression. J Exp Med (1976) 3.00
Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. II. Adoptive immunization of virus carriers. J Exp Med (1972) 2.68
Resistance and susceptibility of mice to bacterial infection: course of listeriosis in resistant or susceptible mice. Infect Immun (1978) 2.65
Non-neutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis. Nature (1982) 2.64
T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63
Protective monoclonal antibodies recognising stage-specific merozoite antigens of a rodent malaria parasite. Nature (1980) 2.55
Immune response to chemically modified flagellin. II. Evidence for a fundamental relationship between humoral and cell-mediated immunity. J Exp Med (1971) 2.47
Effect of 2',3'-didehydro-3'-deoxythymidine in an in vitro hollow-fiber pharmacodynamic model system correlates with results of dose-ranging clinical studies. Antimicrob Agents Chemother (1994) 2.46
The relationship between humoral and cell-mediated immunity. Transplant Rev (1972) 2.43
The three major antigens on the surface of Plasmodium falciparum merozoites are derived from a single high molecular weight precursor. J Exp Med (1984) 2.40
Immunopathogenesis of acute central nervous system disease produced by lymphocytic choriomeningitis virus. I. Cyclophosphamide-mediated induction by the virus-carrier state in adult mice. J Exp Med (1972) 2.37
Regulation of the immune response. I. Suppression of delayed-type hypersensitivity by T cells from mice expressing humoral immunity. Eur J Immunol (1976) 2.36
Surface antigens of malaria merozoites. A high molecular weight precursor is processed to an 83,000 mol wt form expressed on the surface of Plasmodium falciparum merozoites. J Exp Med (1983) 2.30
B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse. J Exp Med (1979) 2.28
Endogenous gamma interferon mediates resistance to Brucella abortus infection. Infect Immun (1993) 2.24
T-T interactions in the induction of suppressor and helper T cells: analysis of membrane phenotype of precursor and amplifier cells. J Exp Med (1977) 2.22
Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection. J Exp Med (1981) 2.18
Potentiation of experimental arbovirus encephalitis by immunosuppressive doses of cyclophosphamide. Nature (1968) 2.16
Induction or prevention of immunopathological disease by cloned cytotoxic T cell lines specific for lymphocytic choriomeningitis virus. Eur J Immunol (1986) 2.06
Murine lymphocyte surface antigens. Adv Immunol (1979) 2.04
In vivo and in vitro effects of monoclonal antibody to Ly antigens on immunity to infection. Cell Immunol (1982) 1.97
Resistance and susceptibility of mice to bacterial infection: histopathology of listeriosis in resistant and susceptible strains. Infect Immun (1980) 1.97
Adenovirus-induced alterations of the cell growth cycle: a requirement for expression of E1A but not of E1B. J Virol (1983) 1.93
A sensitive rosetting method for detecting subpopulations of lymphocytes which react with alloantisera. J Immunol Methods (1978) 1.91
Immune response to chemically modified flagellin. 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin. J Exp Med (1972) 1.90
Restriction in adoptive transfer of resistance to Listeria monocytogenes. II. Use of congenic and mutant mice show transfer to be H-2K restricted. Cell Immunol (1983) 1.86
Protective monoclonal antibodies define maturational and pH-dependent antigenic changes in Sindbis virus E1 glycoprotein. Virology (1983) 1.86
Macrophage behaviour during the complaisant phase of murine pertussis. Immunology (1969) 1.85
Low zone tolerance to bacterial flagellin in adult rats: a possible role for antigen localized in lymphoid follicles. Proc Natl Acad Sci U S A (1968) 1.81
The lymphocyte surface. I. Relation between Fc receptors, C'3 receptors and surface immunoglobulin. Proc R Soc Lond B Biol Sci (1974) 1.80
Immunosuppression and experimental virus infection of the nervous system. Adv Virus Res (1970) 1.79
Inflammatory process in murine lymphocytic choriomeningitis is maximal in H-2K or H-2D compatible interactions. J Immunol (1976) 1.78
The lymphocyte surface. II. Separation of Fc receptor, C'3 receptor and surface immunoglobulin-bearing lymphocytes. Proc R Soc Lond B Biol Sci (1974) 1.76
Anti-pig IgM antibodies in human serum react predominantly with Gal(alpha 1-3)Gal epitopes. Proc Natl Acad Sci U S A (1993) 1.76
Preferential induction of cell-mediated immunity by chemically modified sheep erythrocytes. Eur J Immunol (1972) 1.73
Endogenous interleukin-12 is involved in resistance to Brucella abortus infection. Infect Immun (1995) 1.70
Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis. Nat Med (1995) 1.70
Which T cells cause graft rejection? Transplantation (1982) 1.69
Characteristics of the protective response of BALB/c mice immunized with a purified Plasmodium yoelii schizont antigen. Clin Exp Immunol (1983) 1.69
Automated colorimetric assay for T cell cytotoxicity. J Immunol Methods (1983) 1.68
"B"-cell stimulation of allogeneic T-cell proliferation in mixed lymphocyte cultures. Nat New Biol (1973) 1.68
Lymphocytic choriomeningitis virus: pathogenesis of acute central nervous system disease. Fed Proc (1972) 1.66
Molecular mechanisms of late apoptotic/necrotic cell clearance. Cell Death Differ (2009) 1.66
Tissue-specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing. Eur J Immunol (1992) 1.64
Fatal Japanese encephalitis virus infection in immunosuppresed spider monkeys. Clin Exp Immunol (1970) 1.61
Immune response to chemically modified flagellin. I. Induction of antibody tolerance to flagellin by acetoacetylated derivatives of the protein. J Exp Med (1971) 1.60
MUC1 cross-reactive Gal alpha(1,3)Gal antibodies in humans switch immune responses from cellular to humoral. Nat Med (1998) 1.58
Mouse macrophage beta subunit (CD11b) cDNA for the CR3 complement receptor/Mac-1 antigen. Immunogenetics (1990) 1.58
Cytokine production in the murine response to brucella infection or immunization with antigenic extracts. Immunology (1993) 1.54
Macrophage activation during experimental murine brucellosis: a basis for chronic infection. Infect Immun (1979) 1.54
Cleavage of bacterial flagellin with cyanogen bromide. Antigenic properties of the protein fragments. Biochem J (1969) 1.53
Separation and functional analysis of subpopulations of lymphocytes bearing complement and Fc receptors. Transplant Rev (1975) 1.53
Mannan mucin-1 peptide immunization: influence of cyclophosphamide and the route of injection. J Immunother (2001) 1.52
Ir gene function in an I-A subregion mutant B6.C-H-2bm12. J Exp Med (1981) 1.51
Cyclophosphamide-potentiated West Nile viral encephalitis: relative influence of cellular and humoral factors. J Infect Dis (1974) 1.51
Protein determination on an automatic spectrophotometer. Anal Biochem (1982) 1.50
The steady state in cellular immunity. II. Immunological complaisance in murine pertussis. Aust J Exp Biol Med Sci (1967) 1.49
Cellular origins of co-stimulator (IL2) and its activity in cytotoxic T lymphocyte responses. J Immunol (1980) 1.48
Tissue expression, structure and function of the murine Ly-6 family of molecules. Immunol Cell Biol (1995) 1.48
Lymphocytic choriomeningitis. Pathogenesis. Prog Med Virol (1974) 1.47
Detection and significance of occult metastases in node-negative breast cancer. Br J Surg (1993) 1.47
Peptide mimics of a tumor antigen induce functional cytotoxic T cells. Nat Biotechnol (1998) 1.46
Isolation of a Plasmodium falciparum rhoptry protein. Mol Biochem Parasitol (1985) 1.45
The human cell-surface glycoproteins HuLy-m5, membrane co-factor protein (MCP) of the complement system, and trophoblast leucocyte-common (TLX) antigen, are CD46. Immunology (1990) 1.45
Cytokine response of T-cell subsets from Brucella abortus-infected mice to soluble Brucella proteins. Infect Immun (1993) 1.44
A simple and rapid acrylamide gel method for estimating the molecular weights of proteins and protein subunits. Anal Biochem (1970) 1.44
Colony-forming cells and colony-stimulating activity during listeriosis in genetically resistant or susceptible mice. Cell Immunol (1986) 1.43
Tumor necrosis factor alpha and interleukin-12 contribute to resistance to the intracellular bacterium Brucella abortus by different mechanisms. Infect Immun (1996) 1.43
Lesions in the blood supply of the papilla in experimental analgesic nephropathy. Med J Aust (1968) 1.42
Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection. J Exp Med (1980) 1.41
Molecular composition of the peri-islet basement membrane in NOD mice: a barrier against destructive insulitis. Diabetologia (2008) 1.41
Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res (1991) 1.41
Serological cross-reaction between high molecular weight proteins synthesized in blood schizonts of Plasmodium yoelii, Plasmodium chabaudi and Plasmodium falciparum. Mol Biochem Parasitol (1983) 1.41
Recombinant interleukin-6 protects mice against experimental bacterial infection. Infect Immun (1992) 1.41
Antibody and T cell responses of patients with adenocarcinoma immunized with mannan-MUC1 fusion protein. J Clin Invest (1997) 1.40
Gal alpha (1,3)Gal, the major xenoantigen(s) recognised in pigs by human natural antibodies. Immunol Rev (1994) 1.40
Mucins: structure, function, and associations with malignancy. Bioessays (1992) 1.40
Molecular cloning of a human immunoglobulin G Fc receptor. Proc Natl Acad Sci U S A (1988) 1.38
Identification of active-site residues of the pro-metastatic endoglycosidase heparanase. Biochemistry (2000) 1.37
Functional heterogeneity of lymphocytic choriomeningitis virus-specfic T lymphocytes. I. Identification of effector amd memory subsets. J Exp Med (1975) 1.37
Partial primary structure of the T4 antigens of mouse and sheep: assignment of intrachain disulfide bonds. Proc Natl Acad Sci U S A (1986) 1.36
Antibody-selected variation and reversion in Sindbis virus neutralization epitopes. J Virol (1986) 1.35